Möchten Sie immer auf dem neuesten Stand bleiben?

Erstellen Sie noch heute ein Leserkonto, um die Branchen und Unternehmen zu verfolgen, die Sie interessieren, und passen Sie Ihr Nachrichten-Dashboard an.

Beim Leserkonto Anmelden Leserkonto Erstellen

11. April 2026 15:54 ET | Quelle: Weiss Ratings

Safe Money Report Claims Evaluated: Health Bomb Analysis by Weiss Ratings Examines Healthcare Cost Pressures, Defensive Investment Strategies, and Economic Risk Factors for 2026

Weiss Ratings' Bomb in the Basement thesis, the Financial Bomb Shelter bundle & the Safe Money Report subscription framework examined for investors in 2026
11. April 2026 15:13 ET | Quelle: Weiss Ratings

Wealth Megatrends Under Investigation: Gold's Hidden 5x Paradox — Weiss Ratings' 2026 Report Identifies End of Nine-Year Silver Mining Suppression as Precious Metals Cycle Enters a New Phase

Weiss Ratings publishes the 2026 Wealth Megatrends Golden Paradox report as Sean Brodrick identifies Silver Cross signal in current precious metals markets
11. April 2026 15:09 ET | Quelle: Gelatine Sculpt

Gelatine Sculpt Unveiled: Does This Pink Gelatin Trick for Weight Loss Legit? Read Gelatine Sculpt Report!

New York City, NY, April 11, 2026 (GLOBE NEWSWIRE) -- The global conversation around innovative weight management solutions continues to evolve in 2026, with increasing attention on simplified,...
11. April 2026 14:43 ET | Quelle: Weiss Ratings

Wealth Megatrends Claims Evaluated: Latest Report Highlights Shifting Gold Market Conditions, $6,900 Price Outlook, and Mining Stock Trends Drawing Increased Attention in 2026

Sean Brodrick's gold cycle thesis, $6,900 price outlook, mining stock leverage analysis, and Wealth Megatrends subscription terms summarized for investors
11. April 2026 12:47 ET | Quelle: The Rosen Law Firm PA

PFSI Investor News: If You Have Suffered Losses in PennyMac Financial Services, Inc. (NYSE: PFSI), You Are Encouraged to Contact The Rosen Law Firm About Your Rights

NEW YORK, April 11, 2026 (GLOBE NEWSWIRE) -- WHY: Rosen Law Firm, a global investor rights law firm, continues to investigate potential securities claims on behalf of shareholders of PennyMac...
11. April 2026 07:00 ET | Quelle: BioNTech SE

BioNTech and DualityBio’s Antibody-Drug Conjugate Trastuzumab Pamirtecan Demonstrated Clinically Meaningful Efficacy in Patients with HER2-Expressing, Recurrent Endometrial Cancer

BioNTech today announced positive results from the primary analysis of a Phase 2 cohort evaluating trastuzumab pamirtecan in HER2+ endometrial cancer.
10. April 2026 23:29 ET | Quelle: NeuroSalt

NeuroSalt Under Investigation: What the 2026 Formulation Transparency Review Reveals About Botanical Ingredients, Dosage Disclosure, and Consumer Verification

What a 2026 ingredient review of NeuroSalt's botanical nerve formula found — and the consumer verification questions most coverage skips.
10. April 2026 23:20 ET | Quelle: Digital Asset Technologies Inc.

Digital Asset Technologies Inc. Announces Intention to Amend and Refile Financial Statements and MD&A

VANCOUVER, BC, April 10, 2026 (GLOBE NEWSWIRE) -- Digital Asset Technologies Inc. (CSE: DATT) (OTCPK: DGTEF) (FSE: 9880) (“DATT” or the “Company”), a technology focused investment issuer, announces...
10. April 2026 22:53 ET | Quelle: Pulsetto

Pulsetto Claims Evaluated: 2026 Update on the Pulsetto Vagus Nerve Stimulator, Features, Pricing, and Consumer Use Considerations

Pulsetto vagus nerve stimulator 2026 update covering Lite vs FIT, pricing context, FCC certification, and consumer wellness use considerations.
10. April 2026 22:35 ET | Quelle: Digital Asset Technologies Inc.

Digital Asset Technologies Inc. Clarifying News Release

VANCOUVER, BC, April 10, 2026 (GLOBE NEWSWIRE) -- Digital Asset Technologies Inc. (CSE: DATT) (OTCPK: DGTEF) (FSE: 988) (“DATT” or the “Company”), a technology focused investment issuer, is issuing...

Vorherige Seite

Nächste Seite